ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains

Shares of ImmuCell Corporation (ICCC) have gained 3.9% since reporting results for the first quarter of 2025. This compares with the S&P 500 index’s 5.5% rise over the same time frame. Over the past month, the stock has jumped 11.2% against the S&P 500’s 13.5% rally.Revenue & Earnings SurgeImmuCell posted a strong financial performance for the first quarter of 2025, delivering a record $8.1 million in product sales, up 11$7.3 million in the prior-year period. The rise marked a continuation of momentu ...